Therapeutic Window of P2Y₁₂ Inhibition: Should the Current Limits Be Modified?

JACC Cardiovasc Interv. 2019 Dec 9;12(23):2434. doi: 10.1016/j.jcin.2019.09.025.

Authors

Iñigo Lozano, Armando Perez de Prado, Jose Maria de la Torre Hernandez, Bruno Garcia Del Blanco, Jose Ramon Rumoroso

PMID: 31806223
DOI: 10.1016/j.jcin.2019.09.025

No abstract available

Publication types

Letter
Comment

MeSH terms

Consensus
Genetic Testing
Percutaneous Coronary Intervention*
Purinergic P2Y Receptor Antagonists*
Treatment Outcome

Substances

Purinergic P2Y Receptor Antagonists